Companies: 10,795·Total market cap: $144.5T
Bayer AG

Bayer AG

BAYRYOTCHealthcare● Active
$10.20
$-0.10(-0.95%)
Market Cap$40.1B
P/E Ratio
52W High$14.85
52W Low$7.19

Bayer AG (BAYRY) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · BAYRY · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$43.78B$46.61B$47.64B$50.74B$44.08B
Cost of Revenue$17.86B$21.27B$19.75B$19.87B$16.82B
Gross Profit$25.92B$25.34B$27.89B$30.87B$27.27B
Gross Margin %(computed)59.21%54.36%58.54%60.84%61.85%
Operating Expenses
R&D Expenses$5.54B$6.21B$5.37B$6.57B$5.41B
G&A Expenses$0.00B$2.57B$2.45B$2.84B$2.96B
Total Operating Expenses$19.24B$22.01B$27.89B$23.54B$20.36B
Operating Income$6.68B$3.33B($0.15B)$6.26B$6.97B
Operating Margin %(computed)15.26%7.14%-0.31%12.35%15.82%
Interest Income$0.28B$0.52B$0.43B$0.38B$0.35B
Interest Expense$1.65B$2.36B$2.05B$1.86B$1.35B
Income Before Tax($3.01B)($2.33B)($1.62B)$4.67B$2.05B
Income Tax Expense$0.45B$0.21B$1.32B$0.50B$1.02B
Net Income($3.48B)($2.55B)($2.94B)$4.15B$1.00B
Net Margin %(computed)-7.94%-5.48%-6.17%8.18%2.27%
Per Share & EBITDA
EPS (Basic)$-0.88$-0.65$-0.75$1.06$0.26
Wtd Avg Shares3.93B3.93B3.93B3.93B3.93B
EBITDA$10.57B$8.81B$4.21B$10.44B$6.97B
EBITDA Margin %(computed)24.16%18.90%8.84%20.58%15.81%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B

Explore more Bayer AG data

About Bayer AG (BAYRY) Income Statement

Bayer AG (BAYRY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BAYRY reported revenue of $43.78B, gross profit of $25.92B (gross margin 59.21%), and net income of ($3.48B) — a net profit margin of -7.94%.

Frequently asked questions

BAYRY · 4 questions

Bayer AG (BAYRY) reported revenue of $43.78B for 2025, down 6.1% year-over-year.

BAYRY revenueBAYRY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08